Trial · NCT01296412
Adverse events80
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 80
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | Sitagliptin +/- Glimepiride | 7 | 326 | 9 |
| other | Diarrhoea | Gastrointestinal disorders | Liraglutide | 35 | 324 | 42 |
| other | Nausea | Gastrointestinal disorders | Sitagliptin +/- Glimepiride | 10 | 326 | 13 |
| other | Nausea | Gastrointestinal disorders | Liraglutide | 63 | 324 | 73 |
| other | Vomiting | Gastrointestinal disorders | Sitagliptin +/- Glimepiride | 6 | 326 | 10 |
| other | Vomiting | Gastrointestinal disorders | Liraglutide | 21 | 324 | 25 |
| other | Decreased appetite | Metabolism and nutrition disorders | Sitagliptin +/- Glimepiride | 4 | 326 | 4 |
| other | Decreased appetite | Metabolism and nutrition disorders | Liraglutide | 21 | 324 | 21 |
| other | Hypoglycaemia | Metabolism and nutrition disorders | Sitagliptin +/- Glimepiride | 41 | 326 | 89 |
| other | Hypoglycaemia | Metabolism and nutrition disorders | Liraglutide | 15 | 324 | 31 |
| serious | Atrial fibrillation | Cardiac disorders | Sitagliptin +/- Glimepiride | 1 | 326 | 1 |
| serious | Atrial fibrillation | Cardiac disorders | Liraglutide | 0 | 324 | 0 |
| serious | Coronary artery disease | Cardiac disorders | Sitagliptin +/- Glimepiride | 1 | 326 | 1 |
| serious | Coronary artery disease | Cardiac disorders | Liraglutide | 0 | 324 | 0 |
| serious | Myocardial infarction | Cardiac disorders | Sitagliptin +/- Glimepiride | 1 | 326 | 1 |
| serious | Myocardial infarction | Cardiac disorders | Liraglutide | 0 | 324 | 0 |
| serious | Inguinal hernia | Gastrointestinal disorders | Sitagliptin +/- Glimepiride | 1 | 326 | 1 |
| serious | Inguinal hernia | Gastrointestinal disorders | Liraglutide | 0 | 324 | 0 |
| serious | Accidental death | General disorders | Sitagliptin +/- Glimepiride | 1 | 326 | 1 |
| serious | Accidental death | General disorders | Liraglutide | 0 | 324 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01296412/events